7961 - 7970 of 8826 Results
Title
Year
- Acoustic Analysis of Intonation in Persons With Parkinson's Disease Receiving Transcranial Magnetic Stimulation and Intensive Voice Treatment2021RESTRICTEDTitle: Acoustic Analysis of Intonation in Persons With Parkinson's Disease Receiving Transcranial Magnetic Stimulation and Intensive Voice TreatmentJournal Name: Journal of VoicePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jvoice.2020.12.019Citation Count: 10
- Parallel development of Parkinson's-specific competencies for exercise professionals and criteria for exercise education programs2023RESTRICTEDTitle: Parallel development of Parkinson's-specific competencies for exercise professionals and criteria for exercise education programsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 112Issue #:Start Page: 105407End Page: 105407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105407Citation Count: 4
- Imaging-based DBS programming help: Does it help?2023RESTRICTEDTitle: Imaging-based DBS programming help: Does it help?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 109Issue #:Start Page: 105362End Page: 105362Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105362Citation Count: 1
- A late-onset neurological disorder: is progression inevitable?2022RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
- A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease2023RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
OPENTitle: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagyJournal Name: SLAS DiscoveryPublisher: Elsevier BVVol: 28Issue #: 3Start Page: 73End Page: 87Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004Best OA location URL: http://slas-discovery.org/article/S2472555222137160/pdfCitation Count: 16
-
OPENTitle: Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopyJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 102024End Page: 102024Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.xpro.2022.102024Best OA location URL: https://doi.org/10.1016/j.xpro.2022.102024Citation Count: 6
- History of high household pesticide use and Parkinson's disease in Brazil2023RESTRICTEDTitle: History of high household pesticide use and Parkinson's disease in BrazilJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105493End Page: 105493Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105493Citation Count: 11
-
OPENTitle: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 107Issue #:Start Page: 105251End Page: 105251Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10028594/pdf/nihms-1882881.pdfCitation Count: 5
- Valbenazine as treatment for Huntington's disease chorea2023RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 5